{"id":141,"date":"2021-03-23T05:23:10","date_gmt":"2021-03-23T05:23:10","guid":{"rendered":"https:\/\/www.axxessbio.com\/?page_id=141"},"modified":"2023-09-15T08:36:23","modified_gmt":"2023-09-15T08:36:23","slug":"assessbio-news","status":"publish","type":"page","link":"https:\/\/www.axxessbio.com\/?page_id=141","title":{"rendered":"News"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"141\" class=\"elementor elementor-141\" data-elementor-settings=\"[]\">\n\t\t\t\t\t\t\t<div class=\"elementor-section-wrap\">\n\t\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-4571340b elementor-section-height-min-height elementor-section-boxed elementor-section-height-default elementor-section-items-middle\" data-id=\"4571340b\" data-element_type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-55ea06fb\" data-id=\"55ea06fb\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-5bd7fecd elementor-widget elementor-widget-heading\" data-id=\"5bd7fecd\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">News<\/h1>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-3e1561e5 elementor-section-full_width elementor-section-height-default elementor-section-height-default\" data-id=\"3e1561e5\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-inner-column elementor-element elementor-element-6d480797\" data-id=\"6d480797\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-75ea5cf9 elementor-widget elementor-widget-text-editor\" data-id=\"75ea5cf9\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t<p>Journey with AxxessBio:<br \/>Stay informed with our latest news, press releases and shared milestones<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-5559cd8b elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"5559cd8b\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-1f59c045\" data-id=\"1f59c045\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-42f747ed elementor-widget elementor-widget-text-editor\" data-id=\"42f747ed\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t<p>Latest News and Releases<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-250fdd26 elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"250fdd26\" data-element_type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4d42ca6d elementor-grid-1 elementor-grid-tablet-1 elementor-posts--thumbnail-left elementor-grid-mobile-1 elementor-widget elementor-widget-posts\" data-id=\"4d42ca6d\" data-element_type=\"widget\" data-settings=\"{&quot;classic_columns&quot;:&quot;1&quot;,&quot;classic_row_gap&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:50,&quot;sizes&quot;:[]},&quot;classic_columns_tablet&quot;:&quot;1&quot;,&quot;classic_columns_mobile&quot;:&quot;1&quot;}\" data-widget_type=\"posts.classic\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-posts-container elementor-posts elementor-posts--skin-classic elementor-grid\">\n\t\t\t\t<article class=\"elementor-post elementor-grid-item post-2228 post type-post status-publish format-standard has-post-thumbnail hentry category-uncategorized\">\n\t\t\t\t<a class=\"elementor-post__thumbnail__link\" href=\"https:\/\/www.axxessbio.com\/?p=2228\" >\n\t\t\t<div class=\"elementor-post__thumbnail\"><img loading=\"lazy\" width=\"382\" height=\"190\" src=\"https:\/\/www.axxessbio.com\/wp-content\/uploads\/2024\/06\/PTC-1.jpg\" class=\"attachment-full size-full\" alt=\"\" decoding=\"async\" srcset=\"https:\/\/www.axxessbio.com\/wp-content\/uploads\/2024\/06\/PTC-1.jpg 382w, https:\/\/www.axxessbio.com\/wp-content\/uploads\/2024\/06\/PTC-1-300x149.jpg 300w\" sizes=\"(max-width: 382px) 100vw, 382px\" \/><\/div>\n\t\t<\/a>\n\t\t\t\t<div class=\"elementor-post__text\">\n\t\t\t\t<h2 class=\"elementor-post__title\">\n\t\t\t<a href=\"https:\/\/www.axxessbio.com\/?p=2228\" >\n\t\t\t\tAxxessBio and PTC Therapeutics introduce Translarna\u2122 for Duchenne muscular dystrophy and Upstaza\u2122 for AADC Deficiency in Southeast Asia\t\t\t<\/a>\n\t\t<\/h2>\n\t\t\t\t<div class=\"elementor-post__excerpt\">\n\t\t\t<p>On 1st November 2023, PTC Therapeutics International Limited, granted exclusive distribution rights to AxxessBio in several countries in Southeast Asia for Translarna\u2122 (ataluren) and a service agreement for Upstaza\u2122 (eladocagene exuparvovec). Translarna\u2122 is indicated for the treatment of Duchenne muscular dystrophy (DMD), resulting from a nonsense mutation in the dystrophin<\/p>\n\t\t<\/div>\n\t\t\t\t\t<a class=\"elementor-post__read-more\" href=\"https:\/\/www.axxessbio.com\/?p=2228\" >\n\t\t\t\tRead More \u00bb\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t<\/article>\n\t\t\t\t<article class=\"elementor-post elementor-grid-item post-2209 post type-post status-publish format-standard has-post-thumbnail hentry category-uncategorized\">\n\t\t\t\t<a class=\"elementor-post__thumbnail__link\" href=\"https:\/\/www.axxessbio.com\/?p=2209\" >\n\t\t\t<div class=\"elementor-post__thumbnail\"><img loading=\"lazy\" width=\"382\" height=\"190\" src=\"https:\/\/www.axxessbio.com\/wp-content\/uploads\/2024\/02\/Axxessbio-Genecebok.jpg\" class=\"attachment-full size-full\" alt=\"\" decoding=\"async\" srcset=\"https:\/\/www.axxessbio.com\/wp-content\/uploads\/2024\/02\/Axxessbio-Genecebok.jpg 382w, https:\/\/www.axxessbio.com\/wp-content\/uploads\/2024\/02\/Axxessbio-Genecebok-300x149.jpg 300w\" sizes=\"(max-width: 382px) 100vw, 382px\" \/><\/div>\n\t\t<\/a>\n\t\t\t\t<div class=\"elementor-post__text\">\n\t\t\t\t<h2 class=\"elementor-post__title\">\n\t\t\t<a href=\"https:\/\/www.axxessbio.com\/?p=2209\" >\n\t\t\t\tGENCEBOK\u00ae (caffeine citrate) for apnoea of prematurity is now approved in Singapore\t\t\t<\/a>\n\t\t<\/h2>\n\t\t\t\t<div class=\"elementor-post__excerpt\">\n\t\t\t<p>AxxessBio is pleased to share that GENCEBOK\u00ae (caffeine citrate) 10 MG\/ML SOLUTION FOR INFUSION has been approved by the Health Sciences Authority (HSA) Singapore for apnoea of prematurity. GENCEBOK\u00ae is the first caffeine citrate approved in Singapore for above indication. GENCEBOK\u00ae was also granted the European Marketing Authorization (EMA) in<\/p>\n\t\t<\/div>\n\t\t\t\t\t<a class=\"elementor-post__read-more\" href=\"https:\/\/www.axxessbio.com\/?p=2209\" >\n\t\t\t\tRead More \u00bb\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t<\/article>\n\t\t\t\t<article class=\"elementor-post elementor-grid-item post-2206 post type-post status-publish format-standard has-post-thumbnail hentry category-uncategorized\">\n\t\t\t\t<a class=\"elementor-post__thumbnail__link\" href=\"https:\/\/www.axxessbio.com\/?p=2206\" >\n\t\t\t<div class=\"elementor-post__thumbnail\"><img loading=\"lazy\" width=\"382\" height=\"190\" src=\"https:\/\/www.axxessbio.com\/wp-content\/uploads\/2024\/02\/Axxessbio-Tepadina-Thiotepa.jpg\" class=\"attachment-full size-full\" alt=\"\" decoding=\"async\" srcset=\"https:\/\/www.axxessbio.com\/wp-content\/uploads\/2024\/02\/Axxessbio-Tepadina-Thiotepa.jpg 382w, https:\/\/www.axxessbio.com\/wp-content\/uploads\/2024\/02\/Axxessbio-Tepadina-Thiotepa-300x149.jpg 300w\" sizes=\"(max-width: 382px) 100vw, 382px\" \/><\/div>\n\t\t<\/a>\n\t\t\t\t<div class=\"elementor-post__text\">\n\t\t\t\t<h2 class=\"elementor-post__title\">\n\t\t\t<a href=\"https:\/\/www.axxessbio.com\/?p=2206\" >\n\t\t\t\tTEPADINA\u00ae (thiotepa) for Haematopoietic Stem Cell Transplantation is now approved in Malaysia\t\t\t<\/a>\n\t\t<\/h2>\n\t\t\t\t<div class=\"elementor-post__excerpt\">\n\t\t\t<p>AxxessBio is pleased to announce that TEPADINA\u00ae (thiotepa) 15mg, TEPADINA\u00ae (thiotepa) 100mg and TEPADINA\u00ae (thiotepa) 400mg multi chamber bag have been approved in Malaysia with the following indications: TEPADINA\u00ae is indicated, in combination with other chemotherapy medicinal products: &#8211; With or without total body irradiation (TBI), as conditioning treatment prior<\/p>\n\t\t<\/div>\n\t\t\t\t\t<a class=\"elementor-post__read-more\" href=\"https:\/\/www.axxessbio.com\/?p=2206\" >\n\t\t\t\tRead More \u00bb\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t<\/article>\n\t\t\t\t<article class=\"elementor-post elementor-grid-item post-2202 post type-post status-publish format-standard has-post-thumbnail hentry category-uncategorized\">\n\t\t\t\t<a class=\"elementor-post__thumbnail__link\" href=\"https:\/\/www.axxessbio.com\/?p=2202\" >\n\t\t\t<div class=\"elementor-post__thumbnail\"><img loading=\"lazy\" width=\"382\" height=\"190\" src=\"https:\/\/www.axxessbio.com\/wp-content\/uploads\/2024\/02\/Axxessbio-Tepadina-Thiotepa.jpg\" class=\"attachment-full size-full\" alt=\"\" decoding=\"async\" srcset=\"https:\/\/www.axxessbio.com\/wp-content\/uploads\/2024\/02\/Axxessbio-Tepadina-Thiotepa.jpg 382w, https:\/\/www.axxessbio.com\/wp-content\/uploads\/2024\/02\/Axxessbio-Tepadina-Thiotepa-300x149.jpg 300w\" sizes=\"(max-width: 382px) 100vw, 382px\" \/><\/div>\n\t\t<\/a>\n\t\t\t\t<div class=\"elementor-post__text\">\n\t\t\t\t<h2 class=\"elementor-post__title\">\n\t\t\t<a href=\"https:\/\/www.axxessbio.com\/?p=2202\" >\n\t\t\t\tTEPADINA\u00ae (thiotepa) for Haematopoietic Stem Cell Transplantation is now approved in Thailand\t\t\t<\/a>\n\t\t<\/h2>\n\t\t\t\t<div class=\"elementor-post__excerpt\">\n\t\t\t<p>AxxessBio is pleased to announce that TEPADINA\u00ae (thiotepa) 15mg, TEPADINA\u00ae (thiotepa) 100mg and TEPADINA\u00ae (thiotepa) 400mg multi chamber bag have been approved in Thailand with the following indications: TEPADINA\u00ae is indicated, in combination with other chemotherapy medicinal products: &#8211; With or without total body irradiation (TBI), as conditioning treatment prior<\/p>\n\t\t<\/div>\n\t\t\t\t\t<a class=\"elementor-post__read-more\" href=\"https:\/\/www.axxessbio.com\/?p=2202\" >\n\t\t\t\tRead More \u00bb\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t<\/article>\n\t\t\t\t<\/div>\n\t\t\t\t<nav class=\"elementor-pagination\" role=\"navigation\" aria-label=\"Pagination\">\n\t\t\t<span class=\"page-numbers prev\">&laquo;<\/span>\n<span aria-current=\"page\" class=\"page-numbers current\"><span class=\"elementor-screen-only\">Page<\/span>1<\/span>\n<a class=\"page-numbers\" href=\"https:\/\/www.axxessbio.com\/index.php\/?paged=2&#038;rest_route=%2Fwp%2Fv2%2Fpages%2F141\"><span class=\"elementor-screen-only\">Page<\/span>2<\/a>\n<a class=\"page-numbers\" href=\"https:\/\/www.axxessbio.com\/index.php\/?paged=3&#038;rest_route=%2Fwp%2Fv2%2Fpages%2F141\"><span class=\"elementor-screen-only\">Page<\/span>3<\/a>\n<a class=\"page-numbers\" href=\"https:\/\/www.axxessbio.com\/index.php\/?paged=4&#038;rest_route=%2Fwp%2Fv2%2Fpages%2F141\"><span class=\"elementor-screen-only\">Page<\/span>4<\/a>\n<a class=\"page-numbers next\" href=\"https:\/\/www.axxessbio.com\/index.php?rest_route=%2Fwp%2Fv2%2Fpages%2F141&#038;paged=2\">&raquo;<\/a>\t\t<\/nav>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-147eafaa elementor-section-height-min-height elementor-section-boxed elementor-section-height-default elementor-section-items-middle\" data-id=\"147eafaa\" data-element_type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-3f933c70\" data-id=\"3f933c70\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-957764 elementor-section-full_width elementor-section-height-default elementor-section-height-default\" data-id=\"957764\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-1d5b1fa8\" data-id=\"1d5b1fa8\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-a31aaae elementor-widget elementor-widget-text-editor\" data-id=\"a31aaae\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t<p>Interested in Partnering Up?<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7d35ec24 elementor-widget elementor-widget-text-editor\" data-id=\"7d35ec24\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t<p>At AxxessBio, we are continuously looking for partnerships to bring new innovative therapies for patients all around Asia<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-476548bd elementor-widget elementor-widget-button\" data-id=\"476548bd\" data-element_type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t<a href=\"https:\/\/www.axxessbio.com\/?page_id=1916\" class=\"elementor-button-link elementor-button elementor-size-lg\" role=\"button\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-text\">Get In Touch<\/span>\n\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-693810a\" data-id=\"693810a\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap\">\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>News Journey with AxxessBio:Stay informed with our latest news, press releases and shared milestones Latest News and Releases Interested in Partnering Up? At AxxessBio, we are continuously looking for partnerships to bring new innovative therapies for patients all around Asia Get In Touch<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"footnotes":""},"_links":{"self":[{"href":"https:\/\/www.axxessbio.com\/index.php?rest_route=\/wp\/v2\/pages\/141"}],"collection":[{"href":"https:\/\/www.axxessbio.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.axxessbio.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.axxessbio.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.axxessbio.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=141"}],"version-history":[{"count":18,"href":"https:\/\/www.axxessbio.com\/index.php?rest_route=\/wp\/v2\/pages\/141\/revisions"}],"predecessor-version":[{"id":2161,"href":"https:\/\/www.axxessbio.com\/index.php?rest_route=\/wp\/v2\/pages\/141\/revisions\/2161"}],"wp:attachment":[{"href":"https:\/\/www.axxessbio.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=141"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}